Procept Free Cash Flow Per Share vs Begin Period Cash Flow Analysis

PRCT Stock

USD 97.29 1.98 1.99%

Procept Biorobotics financial indicator trend analysis is much more than just breaking down Procept Biorobotics Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Procept Biorobotics Corp is a good investment. Please check the relationship between Procept Biorobotics Free Cash Flow Per Share and its Begin Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procept Biorobotics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Free Cash Flow Per Share vs Begin Period Cash Flow

Free Cash Flow Per Share vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Procept Biorobotics Corp Free Cash Flow Per Share account and Begin Period Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between Procept Biorobotics' Free Cash Flow Per Share and Begin Period Cash Flow is -0.75. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Procept Biorobotics Corp, assuming nothing else is changed. The correlation between historical values of Procept Biorobotics' Free Cash Flow Per Share and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Procept Biorobotics Corp are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Free Cash Flow Per Share i.e., Procept Biorobotics' Free Cash Flow Per Share and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.75

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Procept Biorobotics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Procept Biorobotics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procept Biorobotics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Selling General Administrative is likely to drop to about 70.4 M in 2024. Issuance Of Capital Stock is likely to drop to about 108.9 M in 2024

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	3.0M	4.3M	3.8M	3.6M
Interest Income	121K	2.5M	5.6M	5.8M

Depreciation And Amortization Interest Income

Procept Biorobotics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Total Assets		0.94	0.93	0.92	0.96	-0.9	0.96	0.78	0.83	-0.95	-0.92	0.8	0.98	0.81	0.83	0.13	0.94	0.98	0.76	0.71	-0.85	0.9	0.95	0.95	-0.77	0.96
Short Long Term Debt Total	0.94		0.96	0.95	0.86	-0.96	0.85	0.83	0.83	-0.84	-0.93	0.83	0.89	0.86	0.86	0.25	0.97	0.89	0.76	0.71	-0.66	0.89	0.88	0.88	-0.56	0.87
Other Current Liab	0.93	0.96		1.0	0.86	-0.84	0.85	0.88	0.87	-0.78	-0.94	0.89	0.84	0.96	0.97	0.24	0.88	0.84	0.81	0.74	-0.73	0.98	0.85	0.89	-0.62	0.87
Total Current Liabilities	0.92	0.95	1.0		0.84	-0.82	0.83	0.89	0.89	-0.76	-0.95	0.9	0.82	0.97	0.98	0.18	0.87	0.82	0.83	0.76	-0.71	0.99	0.82	0.88	-0.6	0.85
Total Stockholder Equity	0.96	0.86	0.86	0.84		-0.82	1.0	0.81	0.87	-0.97	-0.92	0.84	0.95	0.74	0.77	0.07	0.87	0.95	0.81	0.79	-0.92	0.84	0.95	0.99	-0.87	1.0
Other Liab	-0.9	-0.96	-0.84	-0.82	-0.82		-0.82	-0.73	-0.74	0.87	0.86	-0.71	-0.9	-0.69	-0.69	-0.16	-0.99	-0.9	-0.67	-0.65	0.58	-0.74	-0.86	-0.83	0.49	-0.84
Net Tangible Assets	0.96	0.85	0.85	0.83	1.0	-0.82		0.76	0.83	-0.97	-0.9	0.8	0.96	0.71	0.75	0.13	0.87	0.96	0.76	0.75	-0.93	0.82	0.96	0.98	-0.89	1.0
Property Plant And Equipment Net	0.78	0.83	0.88	0.89	0.81	-0.73	0.76		0.99	-0.67	-0.96	0.99	0.68	0.9	0.89	-0.06	0.75	0.68	0.98	0.96	-0.6	0.89	0.66	0.86	-0.51	0.81
Current Deferred Revenue	0.83	0.83	0.87	0.89	0.87	-0.74	0.83	0.99		-0.75	-0.97	0.99	0.74	0.88	0.87	-0.12	0.76	0.74	0.99	0.97	-0.68	0.89	0.71	0.91	-0.6	0.87
Net Debt	-0.95	-0.84	-0.78	-0.76	-0.97	0.87	-0.97	-0.67	-0.75		0.84	-0.7	-0.98	-0.61	-0.63	-0.05	-0.9	-0.98	-0.68	-0.68	0.86	-0.73	-0.95	-0.94	0.83	-0.97
Retained Earnings	-0.92	-0.93	-0.94	-0.95	-0.92	0.86	-0.9	-0.96	-0.97	0.84		-0.96	-0.85	-0.9	-0.9	-0.01	-0.88	-0.85	-0.94	-0.91	0.74	-0.93	-0.83	-0.96	0.65	-0.93
Accounts Payable	0.8	0.83	0.89	0.9	0.84	-0.71	0.8	0.99	0.99	-0.7	-0.96		0.7	0.9	0.9	-0.01	0.74	0.7	0.97	0.95	-0.68	0.9	0.7	0.89	-0.59	0.84
Cash	0.98	0.89	0.84	0.82	0.95	-0.9	0.96	0.68	0.74	-0.98	-0.85	0.7		0.68	0.7	0.14	0.94	1.0	0.66	0.64	-0.85	0.79	0.97	0.93	-0.79	0.96
Non Current Assets Total	0.81	0.86	0.96	0.97	0.74	-0.69	0.71	0.9	0.88	-0.61	-0.9	0.9	0.68		0.99	0.1	0.73	0.68	0.84	0.76	-0.61	0.98	0.68	0.79	-0.49	0.74
Non Currrent Assets Other	0.83	0.86	0.97	0.98	0.77	-0.69	0.75	0.89	0.87	-0.63	-0.9	0.9	0.7	0.99		0.2	0.74	0.7	0.82	0.74	-0.68	0.99	0.73	0.82	-0.56	0.77
Other Assets	0.13	0.25	0.24	0.18	0.07	-0.16	0.13	-0.06	-0.12	-0.05	-0.01	-0.01	0.14	0.1	0.2		0.2	0.14	-0.26	-0.29	-0.2	0.15	0.34	0.07	-0.18	0.08
Long Term Debt	0.94	0.97	0.88	0.87	0.87	-0.99	0.87	0.75	0.76	-0.9	-0.88	0.74	0.94	0.73	0.74	0.2		0.94	0.69	0.66	-0.67	0.8	0.91	0.87	-0.58	0.89
Cash And Short Term Investments	0.98	0.89	0.84	0.82	0.95	-0.9	0.96	0.68	0.74	-0.98	-0.85	0.7	1.0	0.68	0.7	0.14	0.94		0.66	0.64	-0.85	0.79	0.97	0.93	-0.79	0.96
Net Receivables	0.76	0.76	0.81	0.83	0.81	-0.67	0.76	0.98	0.99	-0.68	-0.94	0.97	0.66	0.84	0.82	-0.26	0.69	0.66		0.99	-0.61	0.84	0.61	0.86	-0.53	0.81
Common Stock Shares Outstanding	0.71	0.71	0.74	0.76	0.79	-0.65	0.75	0.96	0.97	-0.68	-0.91	0.95	0.64	0.76	0.74	-0.29	0.66	0.64	0.99		-0.58	0.76	0.59	0.84	-0.52	0.79
Non Current Liabilities Total	-0.85	-0.66	-0.73	-0.71	-0.92	0.58	-0.93	-0.6	-0.68	0.86	0.74	-0.68	-0.85	-0.61	-0.68	-0.2	-0.67	-0.85	-0.61	-0.58		-0.75	-0.9	-0.89	0.99	-0.9
Inventory	0.9	0.89	0.98	0.99	0.84	-0.74	0.82	0.89	0.89	-0.73	-0.93	0.9	0.79	0.98	0.99	0.15	0.8	0.79	0.84	0.76	-0.75		0.8	0.88	-0.65	0.84
Other Current Assets	0.95	0.88	0.85	0.82	0.95	-0.86	0.96	0.66	0.71	-0.95	-0.83	0.7	0.97	0.68	0.73	0.34	0.91	0.97	0.61	0.59	-0.9	0.8		0.93	-0.85	0.95
Other Stockholder Equity	0.95	0.88	0.89	0.88	0.99	-0.83	0.98	0.86	0.91	-0.94	-0.96	0.89	0.93	0.79	0.82	0.07	0.87	0.93	0.86	0.84	-0.89	0.88	0.93		-0.84	0.99
Total Liab	-0.77	-0.56	-0.62	-0.6	-0.87	0.49	-0.89	-0.51	-0.6	0.83	0.65	-0.59	-0.79	-0.49	-0.56	-0.18	-0.58	-0.79	-0.53	-0.52	0.99	-0.65	-0.85	-0.84		-0.86
Net Invested Capital	0.96	0.87	0.87	0.85	1.0	-0.84	1.0	0.81	0.87	-0.97	-0.93	0.84	0.96	0.74	0.77	0.08	0.89	0.96	0.81	0.79	-0.9	0.84	0.95	0.99	-0.86

Click cells to compare fundamentals

Procept Biorobotics Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Procept Free Cash Flow Per Share vs Begin Period Cash Flow Analysis

Free Cash Flow Per Share vs Begin Period Cash Flow

Free Cash Flow Per Share vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Free Cash Flow Per Share

Begin Period Cash Flow

Procept Biorobotics fundamental ratios Correlations

Procept Biorobotics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Procept Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets
Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 0.99	Total Current Liabilities

Long Term Debt	- 0.99	Other Liab
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Invested Capital	- 0.97	Net Debt
Retained Earnings	- 0.97	Current Deferred Revenue
Net Debt	- 0.97	Net Tangible Assets